More
    Guided Solutions - Connecting Talent With Innovation/div>

    AtriCure treats first patient in the BoxX-NoAF clinical trial

    AtriCure, a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced...

    Penumbra study backs Lightning Flash 2.0 mechanical thrombectomy system

    Penumbra announced positive results from its landmark STORM-PE randomised controlled trial. The study found that the use of the company’s computer-assisted vacuum thrombectomy (CAVT) system,...

    Edge Medical wins CE mark for MSP2000 surgical robot platform

    Edge Medical announced on LinkedIn it received CE mark for MSP2000, its robotic-assisted “super system.” The company said in a LinkedIn post that its system...

    Noah Medical reports positive robotic bronchoscopy data

    Noah Medical announced the presentation of two new data sets highlighting the performance of its Galaxy robotic-assisted platform. Galaxy, a next-generation robotic-assisted bronchoscopy platform, and...

    Science Corp. reports positive results for vision-restoring BCI

    Science Corp. announced clinical trial data demonstrating the efficacy of its Prima brain-computer interface (BCI) retinal implant. Findings published in The New England Journal of...

    Adagio Medical reports findings from ventricular tachycardia study

    Adagio Medical has reported preliminary acute efficacy and safety findings from its FULCRUM-VT Study, assessing the use of Ultralow Temperature Cryoablation (ULTC) for treating...

    Inspire Medical reports positive Inspire V therapy results

    Inspire Medical announced clinical outcomes data for its latest-generation Inspire V neuromodulation system. The Minneapolis-based company reported outcomes from a clinical study in Singapore and its...

    Pulse Biosciences shares strong first-in-human PFA data

    Pulse Biosciences announced clinical study results from a first-in-human study of its nPulse system. The company shared findings from the first-in-human feasibility study of the...

    ACORAI has positive results in heart failure management platform study

    Acorai, a clinical-stage company pioneering non-invasive hemodynamic monitoring for heart failure management, this week announced topline results from the 1,600-patient CAPTURE-HF study (Machine-Learning Estimation...

    Latest articles